K

Kura Oncology, Inc.

142 employees

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

Basic info

biotechnology research

Research and Development

Biotechnology

Oncology

Blood Cancers

Targeted Therapeutics

Health Care

Biomarkers

Genetics

Medical

Biopharma

Solid Tumors

Precision Medicine

2014

$125M

from 7 investors over 7 rounds

K

Kura Oncology, Inc. raised $25M on November 3, 2022

Investors: Bristol-Myers Squibb, UK

K

Kura Oncology, Inc. raised $125M on November 3, 2022

Investors: Hercules Capital, Inc.

K

Kura Oncology, Inc. raised $60M on March 12, 2015

Investors: Nextech Invest, Tavistock Group, ARCH Venture Partners, - and Osage University Partners (OUP)